International Immunology, Vol. 11, No. 4, 553-559,
April 1999
© 1999 Japanese Society for Immunology
Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis
1 Department of Joint Disease and Rheumatism, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
2 Department of Immunology, Juntendo University School of Medicine, Tokyo 113-0033, Japan
3 Molecular Preventive Medicine, School of Medicine, University of Tokyo, Tokyo 113-0033, Japan
4 CREST, Japan Science and Technology Corporation (JST), Japan
Correspondence to: A. Nakajima,
Chemokines and their receptors play critical roles in the selective recruitment of various subsets of leukocytes. Recent studies have indicated that some chemokine receptors are differentially expressed on Th1 and Th2 cells. However, available data concerning the presence of T cells with a Th1 or a Th2 character and the expression of chemokine receptors on infiltrating T cells in the rheumatic joint are still limited. In this study, we investigated the expression of CC chemokine receptor 4 (CCR4) and CCR5, which have been shown to be preferentially expressed on Th2 and Th1 respectively on T cells from rheumatoid arthritis (RA) patients. Although both CCR5+ and CCR4+ CD4+ T cell populations were observed in peripheral blood mononuclear cells from healthy controls and osteoarthritis patients, these cell populations were decreased in patients with active RA. In contrast, the vast majority of synovial fluid (SF) T cells from active RA patients expressed CCR5 but not CCR4. CCR5 ligands, MIP-1
and RANTES, were found in RA SF at high levels. CCR5+ CD4+ T cells from SF mononuclear cells of RA patients produced IFN-
but not IL-4 in response to anti-CD3 stimulation in vitro. These results indicated that differential expression of chemokine receptors plays a critical role for selective recruitment of pro-inflammatory T cells into the joints of RA.
Keywords: chemokine, chemokine receptor, rheumatoid arthritis, Th1
Transmitting editor: M. Miyasaka
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C McKinney, M E Merriman, P T Chapman, P J Gow, A A Harrison, J Highton, P B B Jones, L McLean, J L O'Donnell, V Pokorny, et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis Ann Rheum Dis, March 1, 2008; 67(3): 409 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mohan and T. B. Issekutz Blockade of Chemokine Receptor CXCR3 Inhibits T Cell Recruitment to Inflamed Joints and Decreases the Severity of Adjuvant Arthritis J. Immunol., December 15, 2007; 179(12): 8463 - 8469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Okamoto and N. Kamatani A CCR-5 antagonist inhibits the development of adjuvant arthritis in rats Rheumatology, February 1, 2006; 45(2): 230 - 232. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Spagnolo, E. A. Renzoni, A. U. Wells, S. J. Copley, S. R. Desai, H. Sato, J. C. Grutters, A. Abdallah, A. Taegtmeyer, R. M. du Bois, et al. C-C Chemokine Receptor 5 Gene Variants in Relation to Lung Disease in Sarcoidosis Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 721 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. de Lemos, J. E. Christensen, A. Nansen, T. Moos, B. Lu, C. Gerard, J. P. Christensen, and A. R. Thomsen Opposing Effects of CXCR3 and CCR5 Deficiency on CD8+ T Cell-Mediated Inflammation in the Central Nervous System of Virus-Infected Mice J. Immunol., August 1, 2005; 175(3): 1767 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Aeberli, M. Seitz, P. Juni, and P. M. Villiger Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-{alpha} inhibitors Rheumatology, February 1, 2005; 44(2): 172 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Stanford and T. B. Issekutz The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo J. Leukoc. Biol., November 1, 2003; 74(5): 791 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gao, X.-Y. Zhou, Y. Yashiro-Ohtani, Y.-F. Yang, N. Sugimoto, S. Ono, T. Nakanishi, S. Obika, T. Imanishi, T. Egawa, et al. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3 J. Leukoc. Biol., February 1, 2003; 73(2): 273 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Krauss-Etschmann, E. Sammler, S. Koletzko, N. Konstantopoulos, D. Aust, B. Gebert, B. Luckow, D. Reinhardt, and D. J. Schendel Chemokine Receptor 5 Expression in Gastric Mucosa of Helicobacter pylori-Infected and Noninfected Children Clin. Vaccine Immunol., January 1, 2003; 10(1): 22 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gerli, C. Lunardi, and C. Pitzalis Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis Rheumatology, December 1, 2002; 41(12): 1341 - 1345. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lohmann, S. Laue, U. Nietzschmann, T.M. Kapellen, I. Lehmann, S. Schroeder, R. Paschke, and W. Kiess Reduced Expression of Th1-Associated Chemokine Receptors on Peripheral Blood Lymphocytes at Diagnosis of Type 1 Diabetes Diabetes, August 1, 2002; 51(8): 2474 - 2480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Smith and M. K. Haynes Rheumatoid Arthritis--A Molecular Understanding Ann Intern Med, June 18, 2002; 136(12): 908 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tomiyama, T. Matsuda, and M. Takiguchi Differentiation of Human CD8+ T Cells from a Memory to Memory/Effector Phenotype J. Immunol., June 1, 2002; 168(11): 5538 - 5550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Davis, M. Sackler, R. I. Brezinschek, E. Lightfoot, J. L. Bailey, N. Oppenheimer-Marks, and P. E. Lipsky Inflammation, Immune Reactivity, and Angiogenesis in a Severe Combined Immunodeficiency Model of Rheumatoid Arthritis Am. J. Pathol., January 1, 2002; 160(1): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Thompson, L. K. Luyrink, T. B. Graham, M. Tsoras, M. Ryan, M. H. Passo, and D. N. Glass Chemokine Receptor CCR4 on CD4+ T Cells in Juvenile Rheumatoid Arthritis Synovial Fluid Defines a Subset of Cells with Increased IL-4:IFN-{{gamma}} mRNA Ratios J. Immunol., June 1, 2001; 166(11): 6899 - 6906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nagai, S.-i. Hashimoto, T. Yamashita, N. Toyoda, T. Satoh, T. Suzuki, and K. Matsushima Comprehensive gene expression profile of human activated Th1- and Th2-polarized cells Int. Immunol., March 1, 2001; 13(3): 367 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nanki, K. Hayashida, H. S. El-Gabalawy, S. Suson, K. Shi, H. J. Girschick, S. Yavuz, and P. E. Lipsky Stromal Cell-Derived Factor-1-CXC Chemokine Receptor 4 Interactions Play a Central Role in CD4+ T Cell Accumulation in Rheumatoid Arthritis Synovium J. Immunol., December 1, 2000; 165(11): 6590 - 6598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Buckley, N. Amft, P. F. Bradfield, D. Pilling, E. Ross, F. Arenzana-Seisdedos, A. Amara, S. J. Curnow, J. M. Lord, D. Scheel-Toellner, et al. Persistent Induction of the Chemokine Receptor CXCR4 by TGF-{beta}1 on Synovial T Cells Contributes to Their Accumulation Within the Rheumatoid Synovium J. Immunol., September 15, 2000; 165(6): 3423 - 3429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Mattila, A. Nykanen, M. Eloranta, and J. Tarkkanen Adenoids provide a microenvironment for the generation of CD4+, CD45RO+, L-selectin-, CXCR4+, CCR5+ T lymphocytes, a lymphocyte phenotype found in the middle ear effusion Int. Immunol., September 1, 2000; 12(9): 1235 - 1243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hamann and U. Syrbe T-cell trafficking into sites of inflammation Rheumatology, July 1, 2000; 39(7): 696 - 699. [Full Text] [PDF]
|
|
|
|
|
|
F. Hornung, G. Scala, and M. J. Lenardo TNF-{alpha}-Induced Secretion of C-C Chemokines Modulates C-C Chemokine Receptor 5 Expression on Peripheral Blood Lymphocytes J. Immunol., June 15, 2000; 164(12): 6180 - 6187. [Abstract] [Full Text] [PDF]
|
|